Skip to main content
DAEWON PHARMACEUTICAL CO.,LTD logo

DAEWON PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 003220 ISIN · KR7003220001 KO Manufacturing
Open in API
Filings indexed 300 across all filing types
Latest filing 2022-03-10 Director's Dealing
Country KR South Korea
Listing KO 003220

About DAEWON PHARMACEUTICAL CO.,LTD

https://www.daewonpharm.com/eng

Daewon Pharmaceutical Co., Ltd., established in 1958, is a pharmaceutical company focused on improving human health. The company specializes in the development and manufacturing of prescription drugs and finished pharmaceutical products. Its portfolio includes a range of medications such as antipyretics, analgesics, and treatments for respiratory and cardiovascular conditions. Daewon Pharmaceutical maintains a strong commitment to research and development, with a strategic focus on New Chemical Entities (NCE) and Incrementally Modified Drugs (IMD) to provide advanced healthcare solutions.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the shareholding changes of a specific individual (Kim Hyung-sun) at Daewon Pharmaceutical. This type of filing is a standard disclosure for insider transactions or changes in ownership status, which falls under the 'Director's Dealing' category.
2022-03-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory disclosure for insider share ownership changes, which corresponds to the 'Director's Dealing' (DIRS) category in the provided schema.
2022-03-10 Korean
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Daewon Pharmaceutical regarding the adjustment of the conversion price for convertible bonds due to a bonus issue (free capital increase). This type of disclosure, which details changes to the terms of financial instruments (convertible bonds), falls under capital structure and financing updates. Since it specifically addresses the adjustment of conversion prices for debt instruments, it is classified as a Capital/Financing Update (CAP).
2022-03-08 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Daewon Pharmaceutical. It details specific changes in share ownership for directors and major shareholders, including the reason for the change (e.g., receipt of bonus shares). This type of filing is a standard regulatory disclosure regarding insider/major shareholder transactions, which falls under the 'Director's Dealing' (DIRS) category in the provided schema.
2022-03-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the acquisition of shares by an executive (Lee So-ra) of Daewon Pharmaceutical. This type of filing is a standard regulatory requirement for reporting insider transactions, which corresponds to the 'Director's Dealing' category.
2022-02-25 Korean
공정거래자율준수프로그램운영현황(안내공시)
Governance Information Classification · 100% confidence The document is a regulatory disclosure from Daewon Pharmaceutical regarding its 'Compliance Program' (CP) operations, detailing past performance and future plans. It is filed through the Korean Exchange (KRX) system as an 'Information Disclosure' (안내공시). Since it does not fit into specific categories like financial reports, board changes, or dividends, and serves as a general regulatory update on corporate governance and compliance practices, it is best classified as a Regulatory Filing (RNS).
2022-02-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.